Source: http://www.marketsandmarkets.com/” target=”_blank”>MarketsandMarkets
The healthcare simulation market has experienced extensive growth over the past few years, mainly attributed to various advancements in technologies. The increasing focus on training of medical practitioners, rising healthcare costs, growing focus on patient safety, and availability of funds has helped increase the purchasing power of academic institutes, thereby driving the growth of the market.
The healthcare/medical simulation market mainly consists of simulation products and services that are used to train students and healthcare practitioners. The high fidelity manikin/patient simulators market is lucrative for companies to invest in, as it is a major contributor to the market and is forecast to grow at a healthy CAGR from 2012 to 2017. Academics, hospitals, and military are the major end-users of medical simulation products. Academics accounted for the largest market share in 2012 primarily due to increased focus on training of medical students and availability of government funds.
North America is the major market for medical simulation, followed by Europe. This is attributed mainly to the presence of major players in these regions and availability of funds. Growth in the Asian market, especially China and India, is likely to be propelled by the increasing awareness of advanced technologies and focus of major players.
Prominent players in the healthcare/medical simulation market are Laerdal Medical (Norway), CAE Healthcare (Canada), Simulaids (U.S.), Gaumard (U.S.), Kyoto Kagako (Japan), Limbs and Things (U.K.), Education Management Solutions (U.S.), and Mentice AB (Sweden).
This research was conducted by http://www.marketsandmarkets.com/Market-Reports/healthcare-medical-simul… target=”_blank”>MarketsandMarkets, a global market research and consulting company.